<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00640731</url>
  </required_header>
  <id_info>
    <org_study_id>2007-US-001</org_study_id>
    <nct_id>NCT00640731</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of OmniWave Endovascular System to Treat Deep Vein Thrombosis</brief_title>
  <acronym>SONIC I</acronym>
  <official_title>Study of the OmniWave Endovascular System in Subjects With Lower and Upper Extremity Deep Vein Thrombosis - SONIC I Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>OmniSonics Medical Technologies, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>OmniSonics Medical Technologies, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center single arm registry to assess the use of the OmniWave
      Endovascular System in subjects presenting with either lower or upper extremity acute
      (symptoms have been present for greater than or equal to 14 days) DVT.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>March 2008</start_date>
  <completion_date type="Anticipated">July 2008</completion_date>
  <primary_completion_date type="Anticipated">July 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Procedural success rate defined as at least 50% reduction in thrombus burden in each target treatment zone following use of the OmniWave Endovascular System</measure>
    <time_frame>Post-Index procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death, clinically detectable PE, significant vessel damage in target treatment area</measure>
    <time_frame>through 6 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Restoration and maintenance of antegrade in-line flow in target treatment area</measure>
    <time_frame>through 6 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL SF-36</measure>
    <time_frame>through 6 months post-index procedure</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of clinically significant hemolysis</measure>
    <time_frame>Prior to discharge</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Deep Vein Thrombosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OmniWave Endovascular System</intervention_name>
    <description>Treatment with mechanical thrombolysis/thrombectomy</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DVT confirmed by venographic and ultrasound imaging, which has been symptomatic for a
             maximum of 14 days, or diagnosed within past 14 days defined as either first episode
             (no prior history in affected segment), or recurrent episode.

          -  Written informed consent

          -  Agreement to comply with follow up requirements

        Exclusion Criteria:

          -  Known R-L shunt, pulmonary A-V malformation

          -  Excessive tortuosity and/or sharp angulation in target treatment zone

          -  Isolated calf vein thrombosis

          -  Isolated DVT in veins peripheral to axillary vein

          -  Thrombus in peripheral vessel smaller than 5 mm

          -  Target treatment zone cannot be adequately accessed within the 100 cm working length
             of device
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Aruny, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <verification_date>March 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 17, 2008</study_first_submitted>
  <study_first_submitted_qc>March 20, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2008</study_first_posted>
  <last_update_submitted>March 20, 2008</last_update_submitted>
  <last_update_submitted_qc>March 20, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 21, 2008</last_update_posted>
  <responsible_party>
    <name_title>Melina Salerno, Senior Clinical Project Manager</name_title>
    <organization>OmniSonics Medical Technologies, Inc.</organization>
  </responsible_party>
  <keyword>DVT</keyword>
  <keyword>Peripheral Vascular Disease</keyword>
  <keyword>Venous Thrombosis</keyword>
  <keyword>Deep Vein Thrombosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Venous Thrombosis</mesh_term>
    <mesh_term>Upper Extremity Deep Vein Thrombosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

